Several cars burglarized in Fort Myers neighborhood nbc-2.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbc-2.com Daily Mail and Mail on Sunday newspapers.
Clevergene inks MoU with CSIR to sequence SARS-CoV-2 genome
09 December 2020 | News Aim to work together towards unraveling better diagnostics and contributing to India’s efforts of genomic surveillance
Bengaluru based Clevergene has entered into a Memorandum of Understanding (MoU) with the Council of Scientific and Industrial Research- Central Food Technological Research Institute (CSIR-CFTRI) in Mysuru to sequence the SARS-CoV-2 genome and derive valuable insights into virus genome changes (mutations), evolution, epidemiology, and provide an understanding of the spatial and temporal information on infection dynamics of the SARS-CoV-2 virus.
As the COVID-19 pandemic continues to afflict the human population across the globe and many countries are experiencing the second wave of infections, there is a pressing need for India to enhance its pandemic fighting abilities and efforts. The SARS-CoV-2 virus, which is causing the COVID-19 pandemic, continues to mutate into
Envisages development of novel diagnostics and vaccines for Covid-19
Mysore/Mysuru: As part of various initiatives towards mitigating
Covid-19, the city-based CSIR-Central Food Technological Research Institute (CSIR-CFTRI) recently signed a Memorandum of Understanding (MoU) with Clevergene, a Bengaluru-based company, for sequencing of the SARS-CoV-2 genome.
It is expected that the study would provide insights into virus genome changes (mutations), evolution, epidemiology, and provide an understanding of the spatial and temporal information on infection dynamics of the SARS-CoV-2.
Further, under the MoU, the development of novel diagnostics and vaccines for Covid-19 are envisaged. CSIR-CFTRI has also established a COVID Testing Centre in Mysuru, and on an average, more than 1,000 samples are tested in a day.